CA2080354A1 - Utilisation de peptides lies au gene de la calcitonine dans le traitement de la cryptorchidie - Google Patents

Utilisation de peptides lies au gene de la calcitonine dans le traitement de la cryptorchidie

Info

Publication number
CA2080354A1
CA2080354A1 CA002080354A CA2080354A CA2080354A1 CA 2080354 A1 CA2080354 A1 CA 2080354A1 CA 002080354 A CA002080354 A CA 002080354A CA 2080354 A CA2080354 A CA 2080354A CA 2080354 A1 CA2080354 A1 CA 2080354A1
Authority
CA
Canada
Prior art keywords
cgrp
treatment
scrotum
analogue
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002080354A
Other languages
English (en)
Inventor
John M. Hutson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2080354A1 publication Critical patent/CA2080354A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002080354A 1990-04-10 1991-04-10 Utilisation de peptides lies au gene de la calcitonine dans le traitement de la cryptorchidie Abandoned CA2080354A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ9573 1990-04-10
AUPJ957390 1990-04-10

Publications (1)

Publication Number Publication Date
CA2080354A1 true CA2080354A1 (fr) 1991-10-11

Family

ID=3774599

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002080354A Abandoned CA2080354A1 (fr) 1990-04-10 1991-04-10 Utilisation de peptides lies au gene de la calcitonine dans le traitement de la cryptorchidie

Country Status (4)

Country Link
EP (1) EP0527774A4 (fr)
JP (1) JPH05506223A (fr)
CA (1) CA2080354A1 (fr)
WO (1) WO1991015246A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567679A (en) * 1993-12-13 1996-10-22 Daly; Theodore J. Use of CGRP in treating alopecia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4549986A (en) * 1983-12-23 1985-10-29 The Salk Institute For Biological Studies Human CGRP
GB8407907D0 (en) * 1984-03-27 1984-05-02 Sandoz Ltd Organic compounds
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
DE3913954A1 (de) * 1989-04-27 1990-10-31 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen

Also Published As

Publication number Publication date
EP0527774A1 (fr) 1993-02-24
EP0527774A4 (en) 1993-03-31
JPH05506223A (ja) 1993-09-16
WO1991015246A1 (fr) 1991-10-17

Similar Documents

Publication Publication Date Title
US7897571B2 (en) Recombinant lubricin molecules and uses thereof
Philbrick et al. Defining the roles of parathyroid hormone-related protein in normal physiology
Haque et al. Interferon gamma (IFN‐γ) may reverse oral submucous fibrosis
Senior et al. Expression of parathyroid hormone-related protein mRNA in the rat before birth: demonstration by hybridization histochemistry
Lobie et al. Localization of the growth hormone receptor/binding protein in skin
EP0813423B1 (fr) Procede visant a inhiber l'osteolyse et les metastases
JP2010143932A (ja) Ｒａｇｅのリガンド結合部位及びその使用
JP2005508882A (ja) インスリン調節アミノペプチダーゼ（ｉｒａｐ）／アンギオテンシンｉｖ（ａｔ４）受容体活性の調節
WO2001070031A1 (fr) Facteur de croissance d'opioide, modulant l'angiogenese
JPH0581569B2 (fr)
JP2011506414A (ja) 瘢痕を抑制する方法
US8883738B2 (en) Use of a peptide fragment of CD44v6 in the treatment of ophthalmic diseases
JPH10505863A (ja) 脳障害の予防および治療のための方法および医薬組成物
JP2002502369A (ja) 胃腸管上部の機能を強化する方法
WILLIAM et al. Secretin cells in the gastrointestinal tract
WO1996006634A1 (fr) Methode de traitement des hernies inguinales indirectes et des etats pathologiques analogues
US20120225824A1 (en) Mullerian inhibiting substance (mis) analogues
US5677279A (en) Methods and compositions for treating pain with amylin or agonists thereof
US10738123B2 (en) Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia
Summerlee et al. Neutralization of relaxin within the brain affects the timing of birth in rats
JP2001521008A (ja) 哺乳類の中枢神経系ミエリンを一過的に変えて神経再生を促進する免疫組成物及びその使用方法
AU638128B2 (en) Calcitonin gene related peptide for the treatment of undescended testicles
CA2080354A1 (fr) Utilisation de peptides lies au gene de la calcitonine dans le traitement de la cryptorchidie
US20220040253A1 (en) Agonists of Human Kisspeptin Receptor for Modulating Sexual Desire
Blake et al. Effects of injection of anti-luteinizing hormone (LH)-releasing hormone serum and anti-gonadotropin-releasing hormone-associated peptide serum into neonatal rats on LH and follicle-stimulating hormone cells

Legal Events

Date Code Title Description
FZDE Dead